Cyclacel Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK…

Biotechnology
US, Berkeley Heights [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of CYCC's Analysis
CIK: 1130166 CUSIP: 23254L603 ISIN: US23254L8019 LEI: - UEI: -
Secondary Listings
CYCC has no secondary listings inside our databases.